BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.99
+0.17 (0.95%)
May 8, 2026, 4:00 PM EDT - Market closed
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $798.72 million as of May 8, 2026. Its market cap has increased by 430.46% in one year.
Market Cap
798.72M
Enterprise Value
417.88M
1-Year Change
430.46%
Ranking
Category
Stock Price
$17.99
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $798.72M, an increase of 29.87%. That is a compound annual growth rate of 17.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 798.72M | 68.38% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.14B |
| Evotec SE | 1.10B |
| Amphastar Pharmaceuticals | 1.06B |
| Alvotech | 1.00B |
| Cronos Group | 971.11M |
| Pacira BioSciences | 930.18M |
| Eton Pharmaceuticals | 848.70M |
| Esperion Therapeutics | 808.25M |